Menopause (New York, N.Y.)

Menopause · ISSN (e) 1530-0374 · 49 papers in corpus
2019
doi:10.1097/gme.0000000000001161 ·PMID:29994966

ObjectiveThis meta-analysis aims to investigate serum androgen profiles (testosterone, dehydroepiandrosterone sulfate, androstenedione, and sex hormone-binding globulin) in women with premature ovarian failure and to establish if there is e…

2019
doi:10.1097/gme.0000000000001171 ·PMID:29994973

ObjectiveRecent evidence suggests that early or induced menopause increases the risk for cognitive impairment and dementia. Given the potential for different cognitive outcomes due to menopause types, it is important that present research o…

2018
doi:10.1097/gme.0000000000001075 ·PMID:29509595

ObjectiveThe aim of the study was to examine the associations between 25-hydroxyvitamin D (25(OH)D) and biomarkers of ovarian reserve in a large community-based sample of women.MethodsIn 2010 to 2016, women aged 30 to 44 years without any k…

2018
doi:10.1097/gme.0000000000001170 ·PMID:29994971
2017
doi:10.1097/gme.0000000000000776 ·PMID:27922937

ObjectiveOspemifene, an estrogen receptor agonist/antagonist approved for the treatment of dyspareunia and vaginal dryness in postmenopausal women, has potential new indications as an immune modulator. The overall objective of the present s…

2017
doi:10.1097/gme.0000000000000840 ·PMID:28169915

ObjectiveReconstructive surgery for pelvic organ prolapse is plagued with high failure rates possibly due to impaired healing or regeneration of the vaginal wall. Here, we tested the hypothesis that postoperative administration of local est…

2016
doi:10.1097/gme.0000000000000591 ·PMID:26757272

ObjectiveHysterectomy and bilateral salpingo-oophorectomy (BSO) are associated with changes in endogenous hormone levels, yet the risk of venous thrombosis (VT) associated with hysterectomy and BSO is incompletely characterized. This study …

2016
doi:10.1097/gme.0000000000000549 ·PMID:26645820

ObjectiveThe primary objective of this study was to use the Vulvovaginal Symptom Questionnaire (VSQ) to estimate the prevalence and examine the emotional, lifestyle, and sexual impact of vulvovaginal symptoms in postmenopausal women.Methods…

2015
doi:10.1097/gme.0000000000000430 ·PMID:25783468

ObjectiveSuppression of ovarian hormones in premenopausal women on gonadotropin-releasing hormone agonist (GnRH(AG)) therapy can cause fat mass (FM) gain and fat-free mass (FFM) loss. Whether this is specifically caused by a decline in seru…

article 2015
doi:10.1097/gme.0000000000000506 ·PMID:26173076

OBJECTIVE: This study aims to determine the association of preexisting cardiovascular risk factors and cardiovascular diseases with hysterectomy with bilateral ovarian conservation using a case-central design. METHODS: Using the Rochester E…

other 2015
doi:10.1097/GME.0000000000000358 ·PMID:25535964

OBJECTIVE: This study aims to evaluate the diagnostic efficiency of pattern recognition by transvaginal ultrasonography (TVS) and gel infusion sonography (GIS) for identifying endometrial pathology and to compare this setup with a standard …

article 2015
doi:10.1097/gme.0000000000000411 ·PMID:25647777

OBJECTIVE: This study aims to examine whether gynecologic conditions are associated with chronic fatigue syndrome (CFS). METHODS: This study includes a subset of 157 women from a population-based case-control study in Georgia, United States…

2015
doi:10.1097/gme.0000000000000365 ·PMID:25423325

ObjectiveTreatment of menopausal symptoms by compounds with tissue-selective estrogen agonist/antagonist effects, often called selective estrogen receptor modulators, has been researched as an alternative to the use of estrogen therapy. The…

article 2013
doi:10.1097/gme.0b013e3182a3ff45 ·PMID:24067261

OBJECTIVE: Unilateral oophorectomy (UO) is a common surgical practice, yet it remains understudied. We investigated trends in incidence rates, indications, and pathological differences in the right and left ovaries in women younger than 50 …

2012
doi:10.1097/gme.0b013e31824b970a ·PMID:22367731

ObjectiveThis position statement aimed to update the evidence-based position statement published by The North American Menopause Society (NAMS) in 2010 regarding recommendations for hormone therapy (HT) for postmenopausal women. This update…

review 2011
doi:10.1097/gme.0b013e3182127b53 ·PMID:21701433

New therapies for abnormal uterine bleeding have been slow to reach the marketplace for a variety of reasons. These reasons include the availability of cost-effective therapies already available and the extraordinarily difficult and expensi…

article 2011
doi:10.1097/gme.0b013e3181f9fa35 ·PMID:21228728

OBJECTIVE: Cross-sectional studies suggest an association between hysterectomy and negative affect. Using prospective data, we examined the associations of negative affect, attitudes toward aging and menopause, premenstrual symptoms, and va…

2010
doi:10.1097/gme.0b013e3181df4a19 ·PMID:20616674

ObjectiveThere are significant individual differences in the extent to which mood and cognition change as a function of reproductive stage, menstrual phase, postpartum, and hormone therapy use. This review explores the extent to which varia…

2009
doi:10.1097/gme.0b013e31818888f7 ·PMID:19034050

ObjectiveTo investigate the mortality associated with cardiovascular diseases and the effect of estrogen treatment in women who underwent unilateral or bilateral oophorectomy before menopause.DesignWe conducted a cohort study with long-term…

review 2007
doi:10.1097/gme.0b013e31804154d5 ·PMID:17476150

OBJECTIVE: To review postmenopausal hormone therapy for women who have undergone hysterectomy with or without bilateral oophorectomy and to make clinical recommendations regarding changes in regimens compared with those for women with their…

article 2002
doi:10.1097/00042192-200207000-00004 ·PMID:12082359

OBJECTIVE: To examine the utility of a low-dose estrogen and pulsed progestogen hormone replacement therapy (HRT) regimen for add-back during long-term gonadotropin-releasing hormone-agonist (GnRH-agonist) therapy. DESIGN: A pilot clinical …

article 2001
doi:10.1097/00042192-200109000-00012 ·PMID:11528364

OBJECTIVES: Basic fibroblast growth factor (bFGF) is an angiogenic growth factor present in human endometrium and myometrium. Women with leiomyoma-related abnormal uterine bleeding have local dysregulation of bFGF and its type 1 receptor (F…

article 2001
doi:10.1097/00042192-200103000-00011 ·PMID:11256876

OBJECTIVE: To investigate the correlation between benign gynecologic diseases and hormone-dependent malignancies such as endometrial carcinoma in postmenopausal women. DESIGN: We retrospectively analyzed the prevalence of myoma uteri and ad…

article 1998
doi:10.1097/00042192-199805030-00006 ·PMID:9774762

OBJECTIVE: To determine the effects of the androgenic anabolic steroid nandrolone decanoate on uterine endometrium and myometrium and on the mammary gland of female cynomolgus macaques by using morphologic, histomorphometric, and histopatho…